Hamburg, Senior Panel Continue “Rethinking” FDA Organization
This article was originally published in The Tan Sheet
Executive Summary
Commissioner Margaret Hamburg awaits recommendations from a panel of senior agency officials on how to ensure FDA’s centers support Office of Regulatory Affairs’ activities without duplication.
You may also be interested in...
FDA Mulls Another Makeover; Looking To Integrate Agency Functions
FDA Commissioner Hamburg has appointed 10 officials to come up with a plan to realign the agency, with the goal of moving toward a “specialized program-based model.”
FDA Becomes An Agency Of “Directorates” Under Hamburg’s Reorganization
Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the agency’s centers intact, but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.
John Taylor Temporarily Replaces Sharfstein As FDA's Second-In-Command
John Taylor, counselor to FDA Commissioner Margaret Hamburg, will serve temporarily as second-in-command while Hamburg considers how to reorganize the agency's leadership following Principal Deputy Commissioner Josh Sharfstein's departure.